Huntington's disease (HD) is a hereditary neurodegenerative disorder ... The movement disorder is characterized by involuntary movements known as chorea, and by the impairment of voluntary movements.

such as jerking or twitching (chorea) difficulty with coordination trouble learning new information difficulty making decisions Juvenile and late onset forms of Huntington’s disease are also ...

Huntington’s disease (HD) is a progressive ... Involuntary jerking or writhing movements (chorea), muscle rigidity, slow movements, difficulty with balance and coordination.

HD is a rare, adult-onset, autosomal dominant, progressive neurodegenerative disease. George Huntington (Figure 1) was the first person to provide a comprehensive description of adult-onset HD in ...

Neurocrine Biosciences has commenced the Phase I clinical trial of its oral, small molecule vesicular monoamine transporter 2 (VMAT2) inhibitor, NBI-1140675 in healthy adults. The trial aims to assess ...

SOM3355 (bevantolol hydrochloride) hit its objectives in a phase 2 trial in patients with Huntington's disease, improving the involuntary, jerky movements known as chorea that are a key symptom of ...

Biosciences presented data from the KINECT-HD study showcasing significant improvements in chorea across body regions with ...

Drug Significantly Reduces Chorea Symptoms in Patients With Huntington's Disease May 19, 2023 — The drug valbenazine statistically improves chorea, a movement disorder commonly associated with ...

University of Bergen researcher Markus Miettinen is among the first scientists to provide a detailed description of protein clumps associated with Huntington's disease. The findings, which could ...

University of Bergen researcher Markus Miettinen is among the first scientists to provide a detailed description of protein clumps associated with Huntington's disease. The findings, which could ...